Communication outruns the evidence.
Claims sound stronger than the actual proof stage can support.
The mercuriosity method
Who need investors, surgeons, hospital buyers and regulators to understand the same truth, while the evidence is still developing.
New edition every other week. Unsubscribe anytime.
The problem
Strong ideas, real clinical relevance, founders who know their technology. And still, slow traction. Four patterns show up almost every time.
Claims sound stronger than the actual proof stage can support.
Investors, surgeons and hospital buyers get the same materials, though they need different versions of the same truth.
Founders wait until approval to become visible, while trust should already be compounding.
Deck, website, regulatory file and founder profile were created at different moments, with different assumptions.
The three disciplines
The trio is the methodology. Audits, scorecards and advisories all take one of the three as a prefix.
What you say, and how you say it.
Whether all your expressions tell one coherent story.
Whether the right people see and recognize you.
For whom
Built for surgeon-inventors and early MedTech founders building surgical devices the market has not discovered yet.
My deepest experience is in orthopedics and neurosurgery, where I have helped build companies from concept to acquisition. If your device sits in those fields, you will find the most direct relevance.
Founders in adjacent surgical specialties recognize the same patterns. The free tools are open to them too. Mercuriosity's deepest advisory fit stays with implantable devices in orthopedics and neurosurgery.
Explore the toolsWho I am
Mercuriosity is founded by Nancy Lamerigts, MD PhD, a physician-entrepreneur with twenty years in spine, hospital reality and surgeon relationships through InSpine.
She designed and marketed implants for EIT, now sold by DePuy Synthes under Conduit, and applies the same operating logic across Cresco Spine and Atraxon Biotech.
The Operating Table is the publication by Nancy Lamerigts. Frameworks, teardowns, signal analysis and case breakdowns for pre-market surgical device founders. Every edition serves Communication, Congruence or Visibility.
Read the newsletterChoose your starting point
Start with the frameworks before you change anything. Free, and the fastest way to test whether this voice is for you.
Open the newsletterA short diagnostic on where deck, website, regulatory file and founder profile drift apart. You see the gap before anyone else points it out.
Take the scanA thirty-minute consultation. Bring your Congruence Scan outcome, deck, website or regulatory narrative. You leave with the most concrete observation, whether you work with us or not.
Request a call